Zymeworks, Inc. (ZYME)
23.58
+0.13
(+0.55%)
USD |
NASDAQ |
Mar 19, 14:57
Zymeworks Profit Margin (Quarterly) : -1.64K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Royalty Pharma Plc | 57.23% |
| Krystal Biotech, Inc. | 47.99% |
| Scholar Rock Holding Corp. | -- |
| Xeris Biopharma Holdings, Inc. | 12.91% |
| Stoke Therapeutics, Inc. | -4.13K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.56% |
| Return on Assets | -19.88% |
| Return on Invested Capital | -24.15% |
| Gross Profit Margin (Quarterly) | 32.76% |
| Operating Margin (Quarterly) | -1.76K% |
| Return on Net Operating Assets | -114.6% |